Pinnacle PNFP Q1 2026 Earnings Beat Revenue NA EPS 239
Montero Mining Initiates Drill Program at Elvira Project Advancing Exploration Efforts
Oura Files Confidentially for IPO Smart Ring Maker Eyes Public Market Debut
BIOkey BKYI Reports Strong Q1 2026 Revenue NA EPS Beats
Radian Groups RDN Inigo Deal May Enhance Earnings Growth According to RBC Capital
AMD CEO Anticipates Extended CPU Demand Surge Over Next Five Years
Nvidia Shares Dip Despite Wave of Analyst PriceTarget Increases
EasyJet Assures Summer Operations Unaffected by Jet Fuel Supply Concerns Amid Iran Tensions
ETFs Tailored for the Seasonally Slower Summer Trading Period
Borosil Glass Works Surges Over 200 in One Year Amid Strong Financial Performance
SEER Q1 2026 Earnings Narrower Loss Surprises Stock Rallies
OPTU Q1 2026 Earnings Massive EPS Miss as Company Reports Unexpectedly Wide Loss
Enhabit Inc EHAB Q4 2025 Earnings EPS Narrowly Misses Estimates Stock Edges Higher
ACAD Q1 2026 Earnings EPS Misses Estimates as Biotech Faces Profitability Headwinds
Frontline Plc FRO Q4 2025 Earnings EPS Miss Weighs on Shares as Tanker Market Softens
C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Amid Continued Pipeline Progress
Fortinet Holds Steady Near Support Eyes Resistance Amid Cybersecurity Sector Momentum
Blackrock Core Bond Trust BHK Edges Higher Bond Market Sentiment Lifts ClosedEnd Fund
Tevogen Bio Warrants Hold Flat at 004 as Support and Resistance Converge
Adamas Trust Senior Notes ADAMO Hold Steady Near 2528 Amid Low Volatility
Ponce Financial Group PDLB Climbs 145 as Shares Test Key Resistance Level
INCY Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Decline
AFB Q3 2024 Earnings Solid Net Investment Income Amid Stable Municipal Bond Market
Via Transportation Inc VIA Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction
DocuSign Q1 2026 Earnings EPS Beat Drives Modest Stock Gain
HZO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Marine Retail Environment
Trump Seeks Supreme Court Intervention to Pause TikTok Ban
CREG Q1 2026 Earnings Loss per Share of 003 as Company Continues Strategic Transition
Liminatus Pharma LIMN Shares Slide 325 as Selling Pressure Mounts Near Support